Michael Scolaro

Michael Scolaro

Aug 27, 2017

Group 6 Copy 51
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are climate change and air pollution triggering cardiovascular disease?

    Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

    Does Antidepressant Use by Breastfeeding Mothers Lead to Autism?

    The aim of the current project is to investigate the consequences of developmental exposure to antidepressants...

    Developing a new tissue preservation method inspired by Tardigrades

    There are two routine ways to preserve tissues: formalin-fixed paraffin-embedded preservation (FFPE) and...

    Backer Badge Funded